Overzicht Proefschriften
Tips in using the search/filter fieldsGo to page:
- of 6
- >
Displaying 1-50 of 278 results.
Titel | Promovendus | Promotor 1 | Promotor 2 | Copromotor 1 | Copromotor 2 | Universiteit | Promotiejaar | Trefwoorden |
---|---|---|---|---|---|---|---|---|
Mitochondrial failure in sepsis; Acute mechnisms and long-term consequences. | Henning R.H., prof. dr. | Bouma H.R., PhD | Rijksuniversiteit Groningen (RUG) | 0 | Mitrochondrial failure in Sepsis | |||
Drug development and new targets for redox disturbances in experimental vascular disease | Henning R.H., prof. dr. | Deelman L.E., dr. | Buikema J.H., dr. | Rijksuniversiteit Groningen (RUG) | 2022 | Drug development, redox disturbance, experimental vascular disease | ||
An orchestra in need of a conductor challenges and opportunities in multi-infusion therapy | Doesburg F | Touw D.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2021 | multi-infusion therapy | |||
Rational prescribing in Europe: are future doctors well prepared? | Brinkman D.J., PhD | Agtmael M.A. van, prof. dr. | Richir M.C., MD PhD | Tichelaar J., dr. | Vrije Universiteit Amsterdam (VU) | 2018 | Clinical pharmacology; Pharmacotherapy; Prescribing; | |
Learning in a student-run clinic: a new concept to improve medical education in pharmacotherapy | Schutte T., PhD | Agtmael M.A. van, prof. dr. | Richir M.C., MD PhD | Tichelaar J., dr. | Vrije Universiteit Amsterdam (VU) | 2018 | Pharmacotherapy education; Student-run clinic; Medical education; Workplace learning; Undergraduate education; | |
Pharmacological approaches to optimize TB treatment | Zuur M.A. | Alffenaar J.W.C., prof. dr. | Werf T.S. van der, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2018 | Optimize; Tuberculosis; Treatment; | ||
Clinical pharmcology of ertapenem in the treatment of multidrug-resistant tuberculosis | Rijn S.P. van | Alffenaar J.W.C., prof. dr. | Werf T.S. van der, prof. dr. | Kosterink J.G.W., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2019 | Tuberculosis; multidrug-resistant | |
Optimizing levofloxacin dose in the treatment of multidrug-resistant tuberculosis | Ghimire S. | Alffenaar J.W.C., prof. dr. | Touw D.J., prof. dr. | Werf T.S. van der, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2019 | ||
Clinical pharmacology and therapeutic drug monitoring of voriconazole | Veringa A., PhD | Alffenaar J.W.C., prof. dr. | Kosterink J.G.W., prof. dr. | Werf T.S. van der, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2019 | drug monitoring; voriconazole | |
Therapeutic drug monitoring in tuberculosis treatment | Elsen S.H.J. van den | Alffenaar J.W.C., prof. dr. | Werf T.S. van der, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2020 | drug monitoring, tuberculosis treatment | ||
Clinical pharmacology of novel anticancer agents: bioanalysis - clinical pharmacokinetics - mass balance studies | Nijenhuis C.M., PhD | Beijnen J.H., prof. dr. | Schellens J.H.M., prof. dr. | Rosing H., dr. | Universiteit Utrecht (UU) | 2016 | ||
Towards better fall prevention - examining the interplay between factors that influence gait in older patients | Groot M.H. de, PhD | Beijnen J.H., prof. dr. | Lamoth C.J.C., dr. | Universiteit Utrecht (UU) | 2017 | Falls; Gait analysis; Accelerometry; Frailty; Osteoporosis; Maturation; Medication use; Medication use; Geriatrics; Older patients; | ||
Clinical pharmacology and bioanalysis of antileishmanial drugs : Towards improved treatment strategies for leishmaniasis | Kip A.E., PhD | Beijnen J.H., prof. dr. | Schellens J.H.M., prof. dr. | Dorlo T.P.C., dr. | Universiteit Utrecht (UU) | 2017 | Leishmaniasis; Clinical pharmacology; Bioanalysis; Pharmacokinetics; Pharmacodynamics; Miltefosine; Amphotericin B; Neopterin; | |
Solid dispersions in oncology: a solution to solubility-limited oral drug absorption | Sawicki E., PhD | Beijnen J.H., prof. dr. | Schellens J.H.M., prof. dr. | Nuijen B., dr. | Universiteit Utrecht (UU) | 2017 | Solid dispersions; Pharmacokinetics; Spray drying; Freeze drying; Docetaxel; Paclitaxel; Elacridar; | |
Bioanalysis and clinical pharmacology of tamoxifen in breast cancer | Jager N.G.L., PhD | Beijnen J.H., prof. dr. | Schellens J.H.M., prof. dr. | Rosing H., dr. | Universiteit Utrecht (UU) | 2014 | Cancer; Clinical pharmacology; | |
Mounting an attack on the glioblastoma triad : proliferation, invasion and resistance | Gooijer M.C. de, PhD | Beijnen J.H., prof. dr. | Tellingen O. van, dr. | Universiteit Utrecht (UU) | 2019 | Glioblastoma; Blood-brain barrier; Therapy development; Pharmacology; Cell biology; Combination therapy; Mouse models; | ||
Bioanalysis and biotransformation of tyrosine kinase inhibitors in oncology | Rood J.J.M., PhD | Beijnen J.H., prof. dr. | Sparidans R.W., dr. | Universiteit Utrecht (UU) | 2019 | |||
Unintended effects of anti-hyperglycaemic drugs studied in population-based cohorts | Driessen J.H.M., PhD | Bergh J.P.W. van den, prof. dr. | Vries F. de, prof. dr. | Onzenoort H.A.W. van, PhD | Universiteit Maastricht (UM) | 2017 | Hyperglycaemic drugs; Population-based; | |
Pharmacogenetics of antihypertensive drug treatment | Wieren-de Wijer B.M.A. van, dr. | Boer A. de, prof. dr. | Stricker B.H.C., prof. dr. | Klungel O.H., prof. dr. | Maitland-van der Zee A.H., prof. dr. | Universiteit Utrecht (UU) | 2009 | Pharmacogenetics; Antihypertensive drugs; Study design; Observational studies; UIPS; |
Pediatric type 1 and 2 diabetes mellitus : epidemiology, comorbidities, and medication utilization | Fazeli Farsani S., PhD | Boer A. de, prof. dr. | Knibbe C.A.J., prof. dr. | Vorst M.M.J. van der, dr. | Mantel-Teeuwisse A.K., dr. | Universiteit Utrecht (UU) | 2015 | Adolescents; Children; Comorbidities; Epidemiology; Medication use; Diabetes mellitus; UIPS; |
Performence of statistical methods to control for unmeasured confounding in pharmacoepidemiology : focus on instrumental variable analysis | Uddin M.J., MD PhD | Boer A. de, prof. dr. | Roes K.B.C., prof. dr. | Groenwold R.H.H., dr. | Klungel O.H., prof. dr. | Universiteit Utrecht (UU) | 2014 | Observational studies; Pharmacoepidemiology; Confounding; Statistical methods; Instrumental variables; SCCS; PERR; |
Challenges and opportunities in pharmacogenomics: studies in cardiovascular disease and asthma | Leusink M., PhD | Boer A. de, prof. dr. | Bakker P.I.W. de, prof. dr. | Maitland-van der Zee A.H., prof. dr. | Onland-Moret N.C., dr. | Universiteit Utrecht (UU) | 2015 | Pharmacogenomics; Cardiovascular disease; Asthma; Genomics; Genetics; Pharmacology; Statins; Inhaled corticosteroids; Cholesterol; |
Methodological approaches to the pharmacogenomics of statins | Peters B.J.M., dr. | Boer A. de, prof. dr. | Maitland-van der Zee A.H., prof. dr. | Klungel O.H., prof. dr. | Universiteit Utrecht (UU) | 2010 | Methodology; Statins; Pharmacogenomics; | |
Adverse drug reactions of angiotensin-converting enzyme inhibitors : towards precicion medicine | Mahmoud Pour S.H., PhD | Boer A. de, prof. dr. | Asselbergs F.W., prof. dr. MD FES | Maitland-van der Zee A.H., prof. dr. | Universiteit Utrecht (UU) | 2016 | Adverse drug reaction; Pharmacoepidemiology; Pharmacovigilance; ACE Inhibitors | |
Risk factors and treatment of paediatric chronic diseases - Type 1 diabetes, asthma and allergy | Ahmadizar F., PhD | Boer A. de, prof. dr. | Maitland-van der Zee A.H., prof. dr. | Universiteit Utrecht (UU) | 2016 | Children; Diabetes mellitus; Allergy | ||
Harmonising relative effectiveness assessments of medicines in Europe | Kleijnen S., PhD | Boer A. de, prof. dr. | Leufkens H.G.M., prof. dr. | Goettsch W.G., dr. | Universiteit Utrecht (UU) | 2016 | Medicines; Relative effectiveness; Reimbursement; Harmonisation; Europe; Methods; Health technology assessment (HTA); | |
Challenges in the clinical development of orphan drugs | Kreeftmeijer-Vegter A.R., PhD | Boer A. de, prof. dr. | Vries P.J. de, dr. | Universiteit Utrecht (UU) | 2015 | Orphan drugs; Clinical development; Paediatric formulation; Pharmacokinetics; Efficacy; Safety; Regulatory; | ||
Antiplatelet drugs for secondary prevention of cardiovascular diseases : drug utilization, effectiveness, and safety | Noorsyahdy A.Y., MD PhD | Boer A. de, prof. dr. | Klungel O.H., prof. dr. | Deneer V.H.M., dr. | Universiteit Utrecht (UU) | 2017 | Antiplatelet drugs; Secondary prevention; Myocardial infarction; Ischemic stroke; Cardiac arrest; Pharmacogenetics; | |
Unravelling the link between diabetes, insulin treatment and breast cancer | Bronsveld H.K., PhD | Boer A. de, prof. dr. | Bruin M.L. de, prof. dr. | Schmidt M.K., dr. ir. | Universiteit Utrecht (UU) | 2017 | Breast cancer; Risk factors; Diabetes mellitus; Insulin growth factor; Diabetes treatment; | |
Assessing long-term and rare adverse effects of medicines | Duijnhoven R.G., PhD | Boer A. de, prof. dr. | Hoes A.W., prof. dr. | Bruin M.L. de, prof. dr. | Straus S.M.J.M., dr. | Universiteit Utrecht (UU) | 2016 | Adverse effects; Case-control studies; Clinical trials; Cohort studies; Long-term consequences; Medicines; Regulatory; |
Precision anticoagulation with vitamin K antagonists in children | Maagdenberg H., PhD | Boer A. de, prof. dr. | Maitland-van der Zee A.H., prof. dr. | Bierings M.B., dr. | Universiteit Utrecht (UU) | 2018 | Anticoagulation; Thrombosis; Bleedings; Children; Adolescents; Pharmacogenetics; Acenocoumarol; Phenprocoumon; Personalized medicine; Medicines; | |
Osteoarthritis : association with diabetes mellitus, and treatment-related outcomes | Nielen J.T.H., PhD | Boonen A.E.R.C.H., prof. dr. | Dagnelie P.C., prof. dr. | Vries F. de, prof. dr. | Bemt B.J.F. van den, dr. | Universiteit Maastricht (UM) | 2018 | Osteoarthritis; Diabetes mellitus; Hip; Knee; Treatment outcomes; |
Assessing the impact of gout:validating and understanding outcomes | Spaetgens B.P.A., dr | Boonen A.E.R.C.H., prof. dr. | Vries F. de, prof. dr. | Universiteit Maastricht (UM) | 2017 | |||
Clinical decision support in community pharmacy | Heringa M., PhD | Bouma H.R., PhD | Smet P.A.G.M. de, prof. dr. | Floor-Schreudering A., PhD PharmD | Universiteit Utrecht (UU) | 2017 | Patient safety; Clinical decision support system; Community pharmacy; Drug therapy; | |
Readmission to primary care : the role of community pharmacists post-discharge | Ensing H.T., PhD | Bouvy M.L., prof. dr. | Koster E.S., PhD | Dooren A.A. van, dr. | Universiteit Utrecht (UU) | 2017 | Safety; Care continuity; Discharge; Pharmacist home visit; | |
Non-dispensing clinical pharmacists in general practice : training, implementation and clinical effects | Hazen A.C.M., PhD | Bouvy M.L., prof. dr. | Wit N.J. de, prof. dr. | Bont A.A. de, prof. dr. | Zwart D.L.M., dr. | Universiteit Utrecht (UU) | 2018 | Clinical pharmacist; General practice; Medication reviews; Polypharmacy; Hospitalization; Professional identity; |
Supporting patients : pharmacy based interventions to improve medication adherence | Kooij M.J., PhD | Bouvy M.L., prof. dr. | Heerdink E.R., dr. | Dijk C.E.M.J. van, dr. ir. | Universiteit Utrecht (UU) | 2015 | Medication adherence; Pharmacists; Intervention; Pharmacy; Compliance; Community pharmacy; | |
The pursuit of user-friendly medicines : older people in the hot seat | Notenboom K., PhD | Bouvy M.L., prof. dr. | Leufkens H.G.M., prof. dr. | Universiteit Utrecht (UU) | 2017 | Usability; User-friendly; Older patients; Elderly; Medicines; Medication use; Medication errors; Tablet breaking; Swallowing; Medication packaging; | ||
Multi dose drug dispensing for older patients in primary care | Mertens B.J., PhD | Bouvy M.L., prof. dr. | Marum R.J. van, prof. dr. | Kwint H.F., dr. | Universiteit Utrecht (UU) | 2019 | Elderly; Primary care; Multi-dose drug dispensing; | |
Training physicians in electronic prescribing | Stiphout F. van, PhD | Braak E.W.M.T. ter, prof. dr. | Egberts A.C.G., prof. dr. | Zwart-van Rijkom J.E.F., dr. | Aarts J.E.C.M., dr. | Universiteit Utrecht (UU) | 2016 | |
Immunological aspects of conventional and new treatments for cervical cancer, an immunopharmacological approach | Meir H. van | Burg S.H van der, Prof.dr. | Burggraaf J., prof. dr. | Kalkman C.J., prof. dr. | Peeters M.Y.M., dr. | 2017 | Immunotherapy Combined chemo-immunotherapy Cervical cancer HPV16-SLP vaccination Immunomonitoring | |
The road to tailor made azole antifungal therapy | Brüggemann R.J.M., PhD | Burger D.M., prof. dr. | Verweij P.E., prof. dr. | Blijlevens N.M.A., dr. | Radboud Universiteit (RU) | 2011 | Antifungal; clinical pharmacology | |
Optmizing long-term care for hiv-infected patients in Thailand | Ramautarsing R.A., PhD | Burger D.M., prof. dr. | Wit F.W.N.M., dr. | Wijgert J.H.H.M. van de, dr. | Universiteit van Amsterdam (UvA) | 2013 | HIV; clinical pharmacology | |
Clinical pharmacology of nevirapine in HIV-infected patients in Tanzania | Muro E.P., PhD | Burger D.M., prof. dr. | Dolmans W.M.V., prof. dr. | Radboud Universiteit (RU) | 2014 | Clinical pharmacology; HIV; Pharmacokinetics; therapy drug monitoring | ||
Clinical pharmacological studies in tuberculosis patients | Semvua H.H., PhD | Burger D.M., prof. dr. | Aarnoutse R.E., dr. | Boeree M.J., dr. | Radboud Universiteit (RU) | 2014 | Clinical pharmacology; Pharmacokinetics; Tuberculosis | |
Introducing Clinical Pharmacology to Hepatitis C Therapy | Kanter C.T.M.M. de, PhD | Burger D.M., prof. dr. | Drenth J.P.H., prof. dr. | Dofferhoff A.S.M., dr. | Radboud Universiteit (RU) | 2015 | Hepatitis C; Clinical Pharmacology; Therapeutic drug monitoring; drug drug interactions | |
Exposure to antiretroviral agents in hiv-infected pregnant women: not too much-not too little | Colbers E.P.H., PhD | Burger D.M., prof. dr. | Radboud Universiteit (RU) | 2015 | HIV; antiretroviral agents; clinical pharmacology; drug drug interactions | |||
Building a clinical pharmacology framework for the safe and effective use of antifungal agents | Lempers VJC | Burger D.M., prof. dr. | Brüggemann R.J.M., PhD | Aarnoutse R.E., dr. | Radboud Universiteit (RU) | 2016 | Antifungal drugs; Clinical pharmacology; | |
Translational research in tuberculosis: crossing barriers between molecular and clinical pharmacology | Brake L.H.M. te, PHD | Burger D.M., prof. dr. | Russel F.G.M., prof. dr. | Aarnoutse R.E., dr. | Koenderink JB, dr. ir. | Radboud Universiteit (RU) | 2016 | Tuberculosis; Clinical pharmacology; |
Making things easier: how to improve antiviral drug treatment for children | Bastiaans D.E.T., dr. | Burger D.M., prof. dr. | Radboud Universiteit (RU) | 2016 | Clinical pharmacology; Antiviral drug treatment; |
Go to page:
- of 6
- >